WaveMan
WaveMan · Company
CME · Cme Group Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

CME CME (CME) Insider Trading, Ownership & Congress Trades

Financial Services · Security & commodity brokers, dealers, exchanges & services · CIK 0001156375
Quote by TradingView
Congress · 1Form 144 · 4
Funds added, last quarter
838
13F, latest reported quarter

What the filings say about CME

Insiders, 180 days
-$16.4M net sold
1 buyer · 4 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 2 sold
Latest: sale, 2026-06-16
Planned sales (Form 144), 90 days
$4.5M
4 notices

CME insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, CME GROUP INC. insiders sold a net $16.4M of stock across 188 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Cutinho Sunil
Chief Information Officer
SELL
2026-10-27 SEC
5,000
$1.5M
n/a
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Aug 26, 2025.
  • The trade is 25.0% of the 20,037 shares held after it.
  • 1 other insider sold within 30 days.
  • 838 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Information Officer Cutinho Sunil sold about $1.5M of CME on Oct 27, 2026; 1 other insider sold within 30 days and 838 funds added in the latest 13F quarter.
GEPSMAN MARTIN J
Director
SELL
2026-10-22 SEC
400
$121.0K
+0.8%
Context
  • 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Feb 20, 2026.
  • The trade is 1.6% of the 25,244 shares held after it.
  • 1 other insider sold within 30 days.
  • 838 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director GEPSMAN MARTIN J sold about $121.0K of CME on Oct 22, 2026; 1 other insider sold within 30 days and 838 funds added in the latest 13F quarter.
SHEPARD WILLIAM R
Director
BUY
2026-09-28 SECtraded 2026-09-25
292.55
$78.6K
+17.0%
Context
  • 42 earlier Form 4 trades (code P or S) here by this insider (42 buys), the last on Jun 25, 2026.
  • +7.8% median (+5.3% mean) 90-day return after 21 previous buys.
  • The trade is 0.1% of the 263,288 shares held after it.
  • No other insider bought within 30 days.
  • 838 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SHEPARD WILLIAM R bought about $78.6K of CME on Sep 25, 2026; 838 funds added in the latest 13F quarter.
Cook Elizabeth A
Director
SELL
2026-09-14 SEC
500
$140.1K
+12.0%
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Mar 6, 2026.
  • The trade is 2.8% of the 17,916 shares held after it.
  • 1 other insider sold within 30 days.
  • 838 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cook Elizabeth A sold about $140.1K of CME on Sep 14, 2026; 1 other insider sold within 30 days and 838 funds added in the latest 13F quarter.
DUFFY TERRENCE A
Chairman and CEO
SELL
2026-09-11 SECtraded 2026-09-10
14,372
$3.9M
+9.8%
Context
  • 16 earlier Form 4 trades (code P or S) here by this insider (7 buys, 9 sales), the last on May 15, 2026.
  • +10.6% median (+10.6% mean) 90-day return after 2 previous buys.
  • The trade is 34.8% of the 41,258 shares held after it.
  • 1 other insider sold within 30 days.
  • 838 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman and CEO DUFFY TERRENCE A sold about $3.9M of CME on Sep 10, 2026; 1 other insider sold within 30 days and 838 funds added in the latest 13F quarter.
188 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 183 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$16.4M over 180 days
-$4.3M over 90 days
below 85% of Financial Services
Congress
1 member bought in the last year
the lowest in Financial Services
Funds
838 funds bought in last quarter
more than 96% of Financial Services
Revenue
+6.4% year over year
below 60% of Financial Services
Margin
62.5% net margin
more than 88% of Financial Services
Buybacks
no share repurchases reported
Short interest
1.6% of the float short (float per yahoo 2026-10-26) · 3.2 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 27Chief Information Officer Cutinho Sunil sold $1.5M (Oct 27)
Oct 22Director GEPSMAN MARTIN J sold $121.0K (Oct 22)
Oct 22Director MARTIN J GEPSMAN filed to sell $121.0K by Oct 22 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch CME

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+18.5%12M
-16%-3%+9%+22%2025-102025-122026-022026-042026-062026-082026-10 2026-05-15 · DUFFY TERRENCE A sold $7.8M2026-09-10 · DUFFY TERRENCE A sold $3.9M2025-12-11 · DUFFY TERRENCE A sold $3.5M2025-12-11 · DUFFY TERRENCE A sold $3.2M2026-05-15 · DUFFY TERRENCE A sold $2.7M2026-05-18 · Piell Hilda Harris sold $1.8M2025-11-20 · Sammann Derek sold $1.6M2026-03-12 · Vroman Ken sold $1.6M2026-10-27 · Cutinho Sunil sold $1.5M2026-02-23 · Durkin Bryan T sold $1.3M2026-03-17 · Marcus Jonathan L sold $1.0M2026-03-26 · SHEPARD WILLIAM R bought $418.6K2025-11-20 · Sammann Derek sold $362.3K2026-03-06 · Cook Elizabeth A sold $320.0K2025-11-03 · Ford Harold Eugene Jr. sold $263.5K2026-02-06 · Suskind Dennis sold $224.4K2026-09-10 · DUFFY TERRENCE A sold $172.7K2026-09-14 · Cook Elizabeth A sold $140.1K2026-10-22 · GEPSMAN MARTIN J sold $121.0K2026-02-20 · GEPSMAN MARTIN J sold $91.8K2026-09-25 · SHEPARD WILLIAM R bought $78.6K2026-06-25 · SHEPARD WILLIAM R bought $74.9K2025-12-30 · SHEPARD WILLIAM R bought $69.9K2026-03-26 · SHEPARD WILLIAM R bought $18.5K2026-06-25 · SHEPARD WILLIAM R bought $3.3K2025-12-30 · SHEPARD WILLIAM R bought $3.1K2026-10-22 · MARTIN J GEPSMAN filed to sell $121.0K2026-09-16 · JONATHAN MARCUS filed to sell $106.1K2026-09-14 · ELIZABETH ANNE COOK TRUST filed to sell $140.1K2026-09-10 · Terrence Duffy filed to sell $4.1M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns CME: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
30,566,342 sh
$6.7B
VANGUARD CAPITAL MANAGEMENT LLC
23,661,856 sh
$5.2B
STATE STREET CORP
16,346,170 sh
$3.6B
MORGAN STANLEY
9,728,195 sh
$2.1B
GEODE CAPITAL MANAGEMENT, LLC
9,271,309 sh
$2.0B

Congress trades in CME

STOCK Act disclosures, US House only, filed up to 45 days after the trade
Gilbert Cisneros
Sold 2026-06-16 · disclosed 16 days later
$1,001 - $15,000
Gilbert Cisneros
Bought 2026-01-09 · disclosed 35 days later
$1,001 - $15,000
Julie Johnson
Sold 2025-12-18 · disclosed 28 days later
$1,001 - $15,000
Julie Johnson
Sold 2025-11-13 · disclosed 28 days later
$1,001 - $15,000
Valerie Hoyle
Sold 2025-09-23 · disclosed 17 days later
$1,001 - $15,000
All stocks members of Congress are buying · Every member's trades

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

CME planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
MARTIN J GEPSMAN
Filed 2026-10-22
$121.0K
JONATHAN MARCUS
Filed 2026-09-16
$106.1K
ELIZABETH ANNE COOK TRUST
Filed 2026-09-14
$140.1K
Terrence Duffy
Filed 2026-09-10
$4.1M

CME mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
1789 GROWTH AND INCOME FUND
$1.7M position · as of 2026-07-31
5.4%
NYLIM PineStone U.S. Equity Fund
$17.3M position · as of 2026-07-31
4.5%
NYLIM PineStone Global Equity Fund
$1.9M position · as of 2026-07-31
4.4%
Cambiar Aggressive Value ETF
$2.8M position · as of 2026-07-31
4.1%
Invesco Bloomberg Financial Data Providers ETF
$2.0M position · as of 2026-05-31
4.0%
Amplify CWP Enhanced Dividend Income ETF
$286.4M position · as of 2026-06-30
4.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Terrence A. Duffy
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$23.4M
$38.2M
$3.7M
+81%
+65%
2024
$23.9M
$26.8M
$3.4M
+51%
+52%
2023
$23.5M
$34.2M
$3.8M
+31%
+27%
2022
$22.9M
$12.5M
$3.4M
-0%
+4%
2021
$22.9M
$26.9M
$3.3M
+29%
+20%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $16.4M sold by insiders over 180 days, 838 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $4.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
MSTRCOINMORNUPSTIBKRCACCARESHOODRKTSCHWGSDAVE

CME financials

Revenue growth
+6.4%
XBRL, annual
Net margin
62.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$7.0B
four quarters, 2025-10-01 to 2026-09-30
Net margin, TTM
+63.3%
net income over revenue, 2025-10-01 to 2026-09-30
Free cash flow, TTM
$4.3B
operating cash flow minus capex, 2025-10-01 to 2026-09-30
Debt to equity
0.00x
current debt only, 2025-12-31 (9 months older than the period end); equity 2026-09-30
Cash flow to debt
n/a
no debt to cover
Return on equity
+16.1%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on assets
+2.3%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on invested capital
+14.0%
operating income after a 23.5% effective tax rate, over current debt only, 2025-12-31 (9 months older than the period end) plus average of 2025-09-30 and 2026-09-30 minus cash
Return on capital employed
+12.5%
operating income (EBIT proxy) over average of 2025-09-30 and 2026-09-30 minus current liabilities
P/E, trailing
25.27x
close 2026-10-26 over four quarters of diluted EPS, 2025-10-01 to 2026-09-30
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
1.39x
P/E over trailing EPS growth of 18%: four quarters to 2026-09-30 against the four to 2025-09-30
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$6.5B$6.1B$5.6B$5.0B
Operating income$4.2B$3.9B$3.4B$3.0B
Net income$4.1B$3.5B$3.2B$2.7B
EPS (diluted)11.169.678.867.40
Operating cash flow$4.3B$3.7B$3.5B$3.1B
Cash$4.4B$2.9B$2.9B$2.7B
Dividends paid$3.9B$3.6B$3.2B$2.6B
SEC XBRL, fiscal years, as known on 2026-10-28

CME Stock Sonar score 6/7 axes

Find similar shapesCompare

CME ranks highest on financial health (99th percentile) and profitability (68th), and lowest on insider conviction (35th), among Financial Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
68
Inputs
  • Return on equity+16.1% · 67 pct, sector of 205
  • Return on assets+2.3% · 63 pct, sector of 266
  • Return on invested capital+14.0% · 55 pct, sector of 30
  • Return on capital employed+12.5% · 89 pct, sector of 88
Financial health
100
Inputs
  • Debt to equity0.00x · 100 pct, sector of 181
  • Cash flow to debtno debt to cover
Growth
40
Inputs
  • Revenue growth, YoY+6.4% · 40 pct, sector of 245
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
35
Inputs
  • Net Form 4 buying (codes P and S), 180d-$16.4M · 13 pct, sector of 161
  • Insider buyers, 180d1 · 57 pct, sector of 165
Institutional and government
64
Inputs
  • Funds adding, latest quarter838 · 96 pct, sector of 278
  • Congress net buyers, 365d-1 · 10 pct, sector of 31
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$2.3M · 85 pct, sector of 40
Risk and compliance
56
Inputs
  • Short interest, % of float+1.6% · 65 pct, sector of 390
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+13.9% · 46 pct, sector of 175
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

CME filings, in plain words

Are CME insiders buying or selling CME?

In the 180 days to 2026-10-28, CME insiders were net sellers, a net $16.4M: $156.8K of purchases and $16.6M of sales reported on Form 4, by 1 buyer and 4 sellers.

Have members of Congress traded CME?

Yes. In the year to 2026-10-28, 1 House member disclosed buying CME and 2 House members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-06-16.

Are there planned insider sales of CME?

Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $4.5M of stock; the latest, by MARTIN J GEPSMAN, was filed 2026-10-22.

Read the full summary

In the 180 days to 2026-10-28, CME insiders were net sellers of CME, a net $16.4M across purchases and sales reported on Form 4 by 1 buyer and 4 sellers. Sales outweighed purchases more than tenfold by value. None of the 8 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 1 member of Congress disclosed buying CME and 2 members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-06-16. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $4.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies